The human hepatocyte nuclear factor 4 alpha (HNF4A) delivered via lipid nanoparticle messenger RNA (LNP-mRNA) can significantly mitigate the degree of liver fibrosis and restore hepatic cellular activity in mouse models [45]. Here, HNF4A is linked to Hepatic fibrosis.